Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 3/2020

01-12-2020 | Status Epilepticus | Proceedings

Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care

Authors: Alexis N. Simpkins, Katharina M. Busl, Edilberto Amorim, Carolina Barnett-Tapia, Mackenzie C. Cervenka, Monica B. Dhakar, Mark R. Etherton, Celia Fung, Robert Griggs, Robert G. Holloway, Adam G. Kelly, Imad R. Khan, Karlo J. Lizarraga, Hannah G. Madagan, Chidinma L. Onweni, Humberto Mestre, Alejandro A. Rabinstein, Clio Rubinos, Dawling A. Dionisio-Santos, Teddy S. Youn, Lisa H. Merck, Carolina B. Maciel, the Neurotherapeutics Symposium 2019

Published in: Neurocritical Care | Issue 3/2020

Login to get access

Abstract

Effective treatment options for patients with life-threatening neurological disorders are limited. To address this unmet need, high-impact translational research is essential for the advancement and development of novel therapeutic approaches in neurocritical care. “The Neurotherapeutics Symposium 2019—Neurological Emergencies” conference, held in Rochester, New York, in June 2019, was designed to accelerate translation of neurocritical care research via transdisciplinary team science and diversity enhancement. Diversity excellence in the neuroscience workforce brings innovative and creative perspectives, and team science broadens the scientific approach by incorporating views from multiple stakeholders. Both are essential components needed to address complex scientific questions. Under represented minorities and women were involved in the organization of the conference and accounted for 30–40% of speakers, moderators, and attendees. Participants represented a diverse group of stakeholders committed to translational research. Topics discussed at the conference included acute ischemic and hemorrhagic strokes, neurogenic respiratory dysregulation, seizures and status epilepticus, brain telemetry, neuroprognostication, disorders of consciousness, and multimodal monitoring. In these proceedings, we summarize the topics covered at the conference and suggest the groundwork for future high-yield research in neurologic emergencies.
Literature
1.
Fiscella K, Mauksch L, Bodenheimer T, Salas E. Improving care teams’ functioning: recommendations from team science. Jt Comm J Qual Patient Saf. 2017;43:361–8.PubMed
2.
3.
Marulanda-Londono ET, Bell MW, Hope OA, et al. Reducing neurodisparity: recommendations of the 2017 AAN diversity leadership program. Neurology. 2019;92:274–80.PubMed
4.
Rosendale N, Ostendorf T, Evans DA, et al. American academy of neurology members’ preparedness to treat sexual and gender minorities. Neurology. 2019;93:159–66.PubMed
5.
Silver JK. Understanding and addressing gender equity for women in neurology. Neurology. 2019;93:538–49.PubMed
6.
Fournier LE, Hopping GC, Zhu L, et al. Females are less likely invited speakers to the international stroke conference: time’s up to address sex disparity. Stroke. 2020;51:674–8.PubMedPubMedCentral
7.
Silver JK, Bank AM, Slocum CS, et al. Women physicians underrepresented in American Academy of Neurology recognition awards. Neurology. 2018;91:e603–14.PubMedPubMedCentral
8.
Ruzycki SM, Fletcher S, Earp M, Bharwani A, Lithgow KC. Trends in the proportion of female speakers at medical conferences in the United States and in Canada, 2007 to 2017. JAMA Netw Open. 2019;2:e192103.PubMedPubMedCentral
9.
Hocker S, Shah S, Vespa P, et al. The future of neurocritical care research: proceedings and recommendations from the fifth neurocritical care research network conference. Neurocrit Care. 2020;32:311–6.PubMed
10.
McCullagh EA, Nowak K, Pogoriler A, Metcalf JL, Zaringhalam M, Zelikova TJ. Request a woman scientist: a database for diversifying the public face of science. PLoS Biol. 2019;17:e3000212.PubMedPubMedCentral
11.
Lett LA, Murdock HM, Orji WU, Aysola J, Sebro R. Trends in racial/ethnic representation among US medical students. JAMA Netw Open. 2019;2:e1910490.PubMedPubMedCentral
12.
Witteman HO, Hendricks M, Straus S, Tannenbaum C. Are gender gaps due to evaluations of the applicant or the science? A natural experiment at a national funding agency. Lancet. 2019;393:531–40.PubMed
13.
14.
15.
Hall KL, Vogel AL, Stipelman B, Stokols D, Morgan G, Gehlert S. A four-phase model of transdisciplinary team-based research: goals, team processes, and strategies. Transl Behav Med. 2012;2:415–30.PubMedPubMedCentral
16.
Settles IH, Brassel ST, Soranno PA, Cheruvelil KS, Montgomery GM, Elliott KC. Team climate mediates the effect of diversity on environmental science team satisfaction and data sharing. PLoS ONE. 2019;14:e0219196.PubMedPubMedCentral
17.
Vogel AL, Stipelman BA, Hall KL, Nebeling L, Stokols D, Spruijt-Metz D. Pioneering the transdisciplinary team science approach: lessons learned from national cancer institute grantees. J Transl Med Epidemiol. 2014;2:1027.PubMedPubMedCentral
18.
Gomez LE, Bernet P. Diversity improves performance and outcomes. J Natl Med Assoc. 2019;111:383–92.PubMed
19.
Levine SS, Apfelbaum EP, Bernard M, Bartelt VL, Zajac EJ, Stark D. Ethnic diversity deflates price bubbles. Proc Natl Acad Sci USA. 2014;111:18524–9.PubMedPubMedCentral
20.
Sommers SR. On racial diversity and group decision making: identifying multiple effects of racial composition on jury deliberations. J Pers Soc Psychol. 2006;90:597–612.PubMed
21.
Phillips KW, Liljenquist KA, Neale MA. Is the pain worth the gain? The advantages and liabilities of agreeing with socially distinct newcomers. Pers Soc Psychol Bull. 2009;35:336–50.PubMed
22.
Nathan M, Lee N. Cultural diversity, innovation, and entrepreneurship: firm-level evidence from London. Econ Geogr. 2013;89:367–94.
23.
Talke K, Salomo S, Kock A. Top management team diversity and strategic innovation orientation: the relationship and consequences for innovativeness and performance. J Prod Innov Manag. 2011;28:819–32.
24.
Galinsky AD, Todd AR, Homan AC, et al. Maximizing the gains and minimizing the pains of diversity: a policy perspective. Perspect Psychol Sci. 2015;10:742–8.PubMed
25.
de Dios MA, Kuo C, Hernandez L, et al. The development of a diversity mentoring program for faculty and trainees: a program at the Brown Clinical Psychology Training Consortium. Behav Ther (NY). 2013;36:121–6.
26.
Hoppe TA, Litovitz A, Willis KA, et al. Topic choice contributes to the lower rate of NIH awards to African-American/black scientists. Sci Adv. 2019;5:eaaw7238.PubMedPubMedCentral
27.
Provencio JJ, Hemphill JC, Claassen J, et al. The curing coma campaign: framing initial scientific challenges-proceedings of the first curing coma campaign scientific advisory council meeting. In: Neurocritical Care; 2020.
28.
Pritlove C, Juando-Prats C, Ala-Leppilampi K, Parsons JA. The good, the bad, and the ugly of implicit bias. Lancet. 2019;393:502–4.PubMed
29.
Carnethon MR, Kershaw KN, Kandula NR. Disparities research, disparities researchers, and health equity. JAMA. 2019;323:211–2.
30.
Beam DM, Brown J, Kaji AH, et al. Evolution of the strategies to innovate emergency care clinical trials network (SIREN). Ann Emerg Med. 2020;75:400–7.PubMed
31.
Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366:591–600.PubMedPubMedCentral
32.
Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381:2103–13.PubMedPubMedCentral
33.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21.PubMed
34.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18.PubMedPubMedCentral
35.
Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723–31.PubMed
36.
Schwamm LH, Wu O, Song SS, et al. IV Alteplase in MR-selected patients with stroke of unknown onset is safe and feasible: results of the multicenter MR WITNESS Trial (NCT01282242). In: International stroke conference; 17–19 February 2016; Los Angeles, CA.
37.
Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018;379:611–22.PubMed
38.
Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019;380:1795–803.PubMed
39.
Nogueira RG, Ribo M. Endovascular treatment of acute stroke. Stroke. 2019;50:2612–8.PubMed
40.
Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.PubMed
41.
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.PubMed
42.
Simpkins AN, Dias C, Norato G, Kim E, Leigh R, Investigators NIHNHoS. Early change in stroke size performs best in predicting response to therapy. Cerebrovasc Dis. 2017;44:141–9.PubMed
43.
Naqvi I, Simpkins AN, Cullison K, et al. Recurrent thrombolysis of a stuttering lacunar infarction captured on serial MRIs. eNeurologicalSci. 2018;13:14–7.PubMedPubMedCentral
44.
Tahsili-Fahadan P, Simpkins AN, Leigh R, Merino JG. Stuttering lacunar infarction captured on serial MRIs. Neurol Clin Pract. 2016;6:e37–9.PubMedPubMedCentral
45.
46.
Simpkins AN, Janowski M, Oz HS, et al. Biomarker application for precision medicine in stroke. Transl Stroke Res. 2020;11:615–27.PubMed
47.
Nadareishvili Z, Kelley D, Luby M, et al. Molecular signature of penumbra in acute ischemic stroke: a pilot transcriptomics study. Ann Clin Transl Neurol. 2019;6:817–20.PubMedPubMedCentral
48.
Etherton MR, Wu O, Cougo P, et al. Integrity of normal-appearing white matter and functional outcomes after acute ischemic stroke. Neurology. 2017;88:1701–8.PubMedPubMedCentral
49.
Etherton MR, Wu O, Giese AK, et al. White matter integrity and early outcomes after acute ischemic stroke. Transl Stroke Res. 2019;10:630–8.PubMed
50.
Smith EE, Markus HS. New treatment approaches to modify the course of cerebral small vessel diseases. Stroke. 2020;51:38–46.PubMed
51.
Kimberly WT, Bevers MB, von Kummer R, et al. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. 2018;91:e2163–9.PubMedPubMedCentral
52.
Sheth KN, Elm JJ, Molyneaux BJ, et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016;15:1160–9.PubMed
53.
Shuttleworth CW, Andrew RD, Akbari Y, et al. Which spreading depolarizations are deleterious to brain tissue? Neurocrit Care. 2020;32:317–22.PubMedPubMedCentral
54.
Helbok R, Hartings JA, Schiefecker A, et al. What should a clinician do when spreading depolarizations are observed in a patient? Neurocrit Care. 2020;32:306–10.PubMed
55.
Blackburn SL, Grande AW, Swisher CB, Hauck EF, Jagadeesan B, Provencio JJ. Prospective trial of cerebrospinal fluid filtration after aneurysmal subarachnoid hemorrhage via lumbar catheter (PILLAR). Stroke. 2019;50:2558–61.PubMedPubMedCentral
56.
Navarrete-Opazo A, Mitchell GS. Therapeutic potential of intermittent hypoxia: a matter of dose. Am J Physiol Regul Integr Comp Physiol. 2014;307:R1181–97.PubMedPubMedCentral
57.
Seven YB, Mitchell GS. Mechanisms of compensatory plasticity for respiratory motor neuron death. Respir Physiol Neurobiol. 2019;265:32–9.PubMedPubMedCentral
58.
Trumbower RD, Jayaraman A, Mitchell GS, Rymer WZ. Exposure to acute intermittent hypoxia augments somatic motor function in humans with incomplete spinal cord injury. Neurorehabil Neural Repair. 2012;26:163–72.PubMed
59.
Foster GE, Brugniaux JV, Pialoux V, et al. Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans. J Physiol. 2009;587:3287–99.PubMedPubMedCentral
60.
Seven YB, Simon AK, Sajjadi E, Zwick A, Satriotomo I, Mitchell GS. Adenosine 2A receptor inhibition protects phrenic motor neurons from cell death induced by protein synthesis inhibition. Exp Neurol. 2020;323:113067.PubMed
61.
Tadjalli A, Mitchell GS. Cervical spinal 5-HT2A and 5-HT2B receptors are both necessary for moderate acute intermittent hypoxia-induced phrenic long-term facilitation. J Appl Physiol. 1985;2019(127):432–43.
62.
Lovett-Barr MR, Satriotomo I, Muir GD, et al. Repetitive intermittent hypoxia induces respiratory and somatic motor recovery after chronic cervical spinal injury. J Neurosci. 2012;32:3591–600.PubMedPubMedCentral
63.
Navarrete-Opazo A, Vinit S, Dougherty BJ, Mitchell GS. Daily acute intermittent hypoxia elicits functional recovery of diaphragm and inspiratory intercostal muscle activity after acute cervical spinal injury. Exp Neurol. 2015;266:1–10.PubMedPubMedCentral
64.
Hayes HB, Jayaraman A, Herrmann M, Mitchell GS, Rymer WZ, Trumbower RD. Daily intermittent hypoxia enhances walking after chronic spinal cord injury: a randomized trial. Neurology. 2014;82:104–13.PubMedPubMedCentral
65.
Claassen J, Taccone FS, Horn P, et al. Recommendations on the use of EEG monitoring in critically ill patients: consensus statement from the neurointensive care section of the ESICM. Intensive Care Med. 2013;39:1337–51.PubMed
66.
Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol. 2015;32:87–95.PubMedPubMedCentral
67.
Hill CE, Blank LJ, Thibault D, et al. Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients. Neurology. 2019;92:e9–18.PubMedPubMedCentral
68.
Rots ML, van Putten MJ, Hoedemaekers CW, Horn J. Continuous EEG monitoring for early detection of delayed cerebral ischemia in subarachnoid hemorrhage: a pilot study. Neurocrit Care. 2016;24:207–16.PubMed
69.
Rosenthal ES, Biswal S, Zafar SF, et al. Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective study of diagnostic accuracy. Ann Neurol. 2018;83:958–69.PubMedPubMedCentral
70.
Kenney-Jung DL, Vezzani A, Kahoud RJ, et al. Febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol. 2016;80:939–45.PubMedPubMedCentral
71.
Jun JS, Lee ST, Kim R, Chu K, Lee SK. Tocilizumab treatment for new onset refractory status epilepticus. Ann Neurol. 2018;84:940–5.PubMed
72.
Park EG, Lee J, Lee J. The ketogenic diet for super-refractory status epilepticus patients in intensive care units. Brain Dev. 2019;41:420–7.PubMed
73.
Francis BA, Fillenworth J, Gorelick P, Karanec K, Tanner A. The feasibility, safety and effectiveness of a ketogenic diet for refractory status epilepticus in adults in the intensive care unit. Neurocrit Care. 2019;30:652–7.PubMed
74.
Cervenka MC, Hocker S, Koenig M, et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology. 2017;88:938–43.PubMedPubMedCentral
75.
Geocadin RG, Callaway CW, Fink EL, et al. Standards for studies of neurological prognostication in comatose survivors of cardiac arrest: a scientific statement from the American Heart Association. Circulation. 2019;140(9):e517–42.PubMed
76.
McCracken DJ, Lovasik BP, McCracken CE, et al. The intracerebral hemorrhage score: a self-fulfilling prophecy? Neurosurgery. 2019;84:741–8.PubMed
77.
Wartenberg KE, Hwang DY, Haeusler KG, et al. Gap analysis regarding prognostication in neurocritical care: a joint statement from the german neurocritical care society and the neurocritical care society. Neurocrit Care. 2019;31:231–44.PubMedPubMedCentral
78.
Claassen J, Doyle K, Matory A, et al. Detection of brain activation in unresponsive patients with acute brain injury. N Engl J Med. 2019;380:2497–505.PubMed
79.
Amorim E, van der Stoel M, Nagaraj SB, et al. Quantitative EEG reactivity and machine learning for prognostication in hypoxic-ischemic brain injury. Clin Neurophysiol. 2019;130:1908–16.PubMedPubMedCentral
80.
Kondziella D, Friberg CK, Frokjaer VG, Fabricius M, Moller K. Preserved consciousness in vegetative and minimal conscious states: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87:485–92.PubMed
81.
Edlow BL, Chatelle C, Spencer CA, et al. Early detection of consciousness in patients with acute severe traumatic brain injury. Brain. 2017;140:2399–414.PubMedPubMedCentral
82.
Tjepkema-Cloostermans MC, da Silva Lourenco C, Ruijter BJ, et al. Outcome prediction in postanoxic coma with deep learning. Crit Care Med. 2019;47:1424–32.PubMed
83.
Feng Q, Ai YH, Gong H, et al. Characterization of sepsis and sepsis-associated encephalopathy. J Intensive Care Med. 2019;34:938–45.PubMed
84.
Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369:1306–16.PubMedPubMedCentral
85.
Rajaee A, Barnett R, Cheadle WG. Pathogen- and danger-associated molecular patterns and the cytokine response in sepsis. Surg Infect (Larchmt). 2018;19:107–16.
Metadata
Title
Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care
Authors
Alexis N. Simpkins
Katharina M. Busl
Edilberto Amorim
Carolina Barnett-Tapia
Mackenzie C. Cervenka
Monica B. Dhakar
Mark R. Etherton
Celia Fung
Robert Griggs
Robert G. Holloway
Adam G. Kelly
Imad R. Khan
Karlo J. Lizarraga
Hannah G. Madagan
Chidinma L. Onweni
Humberto Mestre
Alejandro A. Rabinstein
Clio Rubinos
Dawling A. Dionisio-Santos
Teddy S. Youn
Lisa H. Merck
Carolina B. Maciel
the Neurotherapeutics Symposium 2019
Publication date
01-12-2020
Publisher
Springer US
Published in
Neurocritical Care / Issue 3/2020
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-020-01085-0

Other articles of this Issue 3/2020

Neurocritical Care 3/2020 Go to the issue

Invited Commentary

Cefepime and Acute Encephalopathy: There’s More to This Story

Original Work

Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case–Control Study

Letters to the editor

Updated Nomenclature of Delirium and Acute Encephalopathy

Original work (Clinical Investigation, Basic Science)

The PET Sandwich: Using Serial FDG-PET Scans with Interval Burst Suppression to Assess Ictal Components of Disease

Viewpoint

Integration of Routine Parental Request of Organ Donation in End-of-Life Care of Children with Neurologic Disorders in the UK: Unresolved Medical, Legal, Cultural, and Religious Challenges

Original Work

Validation of the 2HELPS2B Seizure Risk Score in Acute Brain Injury Patients